Paul Korner's most recent trade in Agile Therapeutics Inc was a trade of 13,500 Common Stock done . Disclosure was reported to the exchange on June 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | Paul Korner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 13,500 | 13,500 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Paul Korner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 4,500 | 4,500 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Paul Korner | Sr. VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 10,000 | 10,000 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Paul Korner | Sr. VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 225,000 | 225,000 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Paul Korner | Sr. VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 173,160 | 173,160 | - | - | Employee Stock Option (Right to Buy) |